Sangamo Therapeutics, Inc
SGMOQ- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001001233
No open-market purchases or sales by Sangamo Therapeutics, Inc insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $29.0K in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Sangamo Therapeutics, Inc as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 122
- −5 vs. Q4 2024
- Shares held
- 52.6M
- −9.02M (−14.6%) vs. Q4 2024
- Total value
- $34.5M
- −$28.4M (−45.2%) vs. Q4 2024
- New holders
- 23
- 33 more added
- Sold out
- 28
- 33 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SGMOQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 6 | $29.0K |
| Q1 2026 | 112 | $26.0M |
| Q4 2025 | 105 | $26.2M |
| Q3 2025 | 112 | $42.1M |
| Q2 2025 | 114 | $39.6M |
| Q1 2025 | 122 | $34.5M |
| Q4 2024 | 128 | $62.9M |
| Q3 2024 | 103 | $48.6M |
| Q2 2024 | 129 | $31.1M |
| Q1 2024 | 131 | $68.2M |
| Q4 2023 | 130 | $47.2M |
| Q3 2023 | 135 | $61.3M |
| Q2 2023 | 152 | $137.4M |
| Q1 2023 | 180 | $197.6M |
| Q4 2022 | 182 | $326.0M |
| Q3 2022 | 197 | $477.2M |
| Q2 2022 | 188 | $371.1M |
| Q1 2022 | 195 | $459.6M |
| Q4 2021 | 193 | $577.0M |
| Q3 2021 | 193 | $679.3M |
| Q2 2021 | 197 | $912.0M |
| Q1 2021 | 203 | $994.7M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Sangamo Therapeutics, Inc; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 562,936 | $369.2K | 0.00% | −15,329−2.7% | Reduced |
| UBS Group AG | 610,966 | $400.8K | 0.00% | +276,805+82.8% | Added |
| Marshall Wace, LLP | 651,906 | $430.3K | 0.00% | +314,776+93.4% | Added |
| Morgan Stanley | 745,761 | $489.1K | 0.00% | −1,135,500−60.4% | Reduced |
| HighTower Advisors, LLC | 760,663 | $498.8K | 0.00% | +3,840+0.5% | Added |
| Two Sigma Investments, LP | 786,745 | $515.9K | 0.00% | −225,895−22.3% | Reduced |
| Two Sigma Advisers, LP | 899,255 | $589.7K | 0.00% | +191,700+27.1% | Added |
| Goldman Sachs Group Inc | 955,239 | $626.4K | 0.00% | −651,670−40.6% | Reduced |
| Gsa Capital Partners LLP | 966,202 | $634.0K | 0.06% | +934,649+2,962.2% | Added |
| Opaleye Management Inc. | 1,055,000 | $691.9K | 0.15% | +1,055,000 | New |
| Charles Schwab Investment Management Inc | 1,097,834 | $720.0K | 0.00% | −41,418−3.6% | Reduced |
| State Street Corp | 1,122,944 | $736.4K | 0.00% | −3,896,091−77.6% | Reduced |
| Millennium Management LLC | 1,172,092 | $768.7K | 0.00% | −1,567,574−57.2% | Reduced |
| Jacobs Levy Equity Management, Inc | 1,297,785 | $851.1K | 0.00% | +555,323+74.8% | Added |
| Susquehanna International Group, LLP | 1,809,550 | $1.19M | 0.00% | +1,524,637+535.1% | Added |
| Ikarian Capital, LLC | 1,860,179 | $1.22M | 0.40% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 1,998,043 | $1.31M | 0.00% | −272,507−12.0% | Reduced |
| Geode Capital Management, LLC | 2,283,450 | $1.50M | 0.00% | +71,601+3.2% | Added |
| Renaissance Technologies LLC | 3,168,107 | $2.08M | 0.00% | +83,230+2.7% | Added |
| BlackRock, Inc. | 5,445,018 | $3.57M | 0.00% | +251,714+4.8% | Added |
| Wasatch Advisors Inc | 6,868,766 | $4.50M | 0.03% | −2,362,739−25.6% | Reduced |
| Vanguard Group Inc | 9,374,728 | $6.15M | 0.00% | 00.0% | Unchanged |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −740,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −456,946−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −351,337−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −250,789−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −165,367−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −152,933−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −136,687−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −105,337−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −79,808−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −64,480−100.0% | Sold out |
| Sageworth Trust Co | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −41,322−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −36,550−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −24,853−100.0% | Sold out |
| Nations Financial Group Inc, | 0 | $0 | 0.00% | −23,386−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −21,817−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −13,712−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −11,343−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −10,185−100.0% | Sold out |
| BFSG, LLC | 0 | $0 | 0.00% | −1,237−100.0% | Sold out |
| Venturi Wealth Management, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Reyes Financial Architecture, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Kohmann Bosshard Financial Services, LLC | 0 | $0 | 0.00% | −155−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |